Posts

Showing posts with the label Contamination Control Strategy

Difference Between LAF and RLAF in Sterile Manufacturing Facilities: Design, Working Principle & GMP Requirements

Image
Difference Between LAF and RLAF in Sterile Manufacturing Facilities: Design, Working Principle & GMP Requirements Difference Between LAF and RLAF in Sterile Manufacturing Facilities: Design, Working Principle & GMP Requirements 1. Introduction In sterile pharmaceutical manufacturing, airflow design is one of the most critical elements of contamination control. Among various airflow concepts, Laminar Air Flow (LAF) and Reverse Laminar Air Flow (RLAF) are often misunderstood, misapplied, or incorrectly justified during GMP inspections. Regulatory authorities expect manufacturers to demonstrate: Clear understanding of airflow principles Scientific rationale for airflow selection Alignment with contamination control strategy (CCS) Consistent application with EU GMP Annex 1 This article provides a complete, practical, and regulatory-focused explanation of the difference between LAF and RLAF in sterile facilities. 2. Why Understanding L...
Post a Comment
Read more

Understanding EU Annex 1 Expectations

Image
The revised EU GMP Annex 1 (2023) strengthens expectations for sterile manufacturing by promoting a risk-based, science-driven Contamination Control Strategy (CCS) . This summary highlights the core principles and practical steps microbiologists and pharma professionals should focus on to achieve compliance. What is Annex 1? Annex 1 is a part of the EU Good Manufacturing Practice (GMP) guidelines that specifically addresses the manufacture of sterile medicinal products. Its objective is to ensure sterile products are produced and controlled to minimize microbiological, particulate, and pyrogenic contamination. Key Focus Areas in the Revised Annex 1 Below are the primary expectations introduced or emphasised in the 2023 revision: a. Contamination Control Strategy (CCS) A documented, site-wide CCS that identifies contamination risks ...
Post a Comment
Read more

Popular posts from this blog

Too Numerous To Count (TNTC) & Too Few To Count (TFTC) in Microbiology: Meaning, Limits, Calculations, and GMP Impact

Image
TNTC & TFTC in Microbiology Explained: Meaning, Count Limits, Calculations, GMP Impact, and Practical Lab Control In microbiology laboratories, plate count results are not just numbers. They guide quality decisions, batch release, investigations, and regulatory compliance. Among the most misunderstood results are Too Numerous To Count (TNTC) and Too Few To Count (TFTC) . Improper interpretation of these results can lead to invalid data, missed contamination risks, and serious GMP observations. This article explains TNTC and TFTC from a scientific, regulatory, and problem-solving perspective , with practical examples from real laboratory situations. Table of Contents (TNTC & TFTC in Microbiology) Introduction Scientific Principle Behind Plate Counts Meaning of TNTC and TFTC Countable Limits and Acceptance Ranges Calculations and Data Handling TNTC vs TFTC Comparison Table Scientific Rationale and Justification Regulatory Expectations (USP, PD...
Read more

Non-Viable Particle Count (NVPC) in Cleanrooms: Principles, Methods & GMP Requirements

Image
Non-Viable Particle Count (NVPC) in Cleanrooms: Principles, Methods & GMP Requirements Non-Viable Particle Count (NVPC) in Cleanrooms: Principles, Methods & GMP Requirements ⬆ Back to Table of Contents 📌 Table of Contents Introduction to Non-Viable Particle Count (NVPC) What Are Non-Viable Particles? Why NVPC Monitoring Is Critical in GMP Cleanrooms Cleanroom Classification Based on NVPC Regulatory Guidelines Governing NVPC NVPC Monitoring Methods Practical GMP Examples Alert and Action Limits for NVPC Trending and Data Integrity Common Regulatory Audit Observations Frequently Asked Questions (Q&A) Conclusion NVPC and Microbial Contamination Relationship Cleanroom Airflow & NVPC Control NVPC in Contamination Control Strategy (CCS) Risk-Based NVPC Monitoring Continuous vs Periodic Monitoring Alert & Action Level Philosophy NVPC Excursion...
Read more

USP 41; Balances Explained (2026): Measurement Uncertainty, Minimum Weight, Audit Readiness; Why USP Revised the Rule

Image
USP <41> Balances (Recent 2026 Update): Measurement Uncertainty, Minimum Weight, Audit Readiness Guide ⚠ INSPECTION WARNING: During recent GMP inspections, regulators cited laboratories for failing to document measurement uncertainty and incorrect minimum weight calculations under USP <41>. One incorrect weighing below validated minimum weight can invalidate sterility tests, assay results, and even entire commercial batches. Hook Line: If your balance does not have a scientifically justified minimum weight and documented uncertainty — your data is at regulatory risk. USP <41> 2026 Key Requirements: Minimum weight formula: m min = 2000 × s Measurement uncertainty must be included in calibration certificates Conformity decision rule must be documented Net sample weight must exceed validated minimum weight Non-compliance may result in GMP audit observation 📑 Table of Contents 1. What Changed in USP <41> (2026 Recent Update) 2. Scientif...
Read more